Results 31 to 40 of about 119,768 (224)

Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial

open access: yesJournal of Dermatological Treatment, 2023
Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia (AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate grades of androgenetic alopecia is not established.
Mithinkumar Balasundaram   +2 more
doaj   +1 more source

Introducing leprosy post-exposure prophylaxis into the health systems of India, Nepal and Indonesia: a case study

open access: yesBMC Health Services Research, 2017
Background Leprosy has a wide range of clinical and socio-economic consequences. India, Indonesia and Nepal contribute significantly to the global leprosy burden. After integration, the health systems are pivotal in leprosy service delivery.
A. Tiwari   +6 more
doaj   +1 more source

Proceedings of a Joint Meeting held between The Norwegian Society of Infectious Diseases and the Royal Society of Tropical Medicine and Hygiene, Oslo, 20th June 2008 [PDF]

open access: yes, 2009
The Royal Society of Tropical Medicine and Hygiene (RSTMH) has a tradition of holding joint meetings with fellow European Societies, providing opportunities to facilitate discussion, exchange information, foster mutual interests and develop collaboration
Myrvang, Bjorn, Newport, Melanie J.
core   +1 more source

The burden of leprosy in Cameroon: fifteen years into the post-elimination era [PDF]

open access: yes, 2016
Cameroon achieved the elimination target of leprosy in 2000, and has maintained this status ever since. However, a number of health districts in the country continue to report significant numbers of leprosy cases.
Bissek, Anne-Cecile Zoung-Kanyi   +6 more
core   +8 more sources

'Go on, just try some!': Meat and meaning-making among South Indian Christians [PDF]

open access: yes, 2008
This is an Author's Accepted Manuscript of an article published in South Asia: Journal of South Asian Studies, 31(1), 36-55, 2008 [copyright Taylor & Francis], available online at: http://www.tandfonline.com/10.1080/00856400701874700.No abstract ...
Staples, J
core   +1 more source

EXPERIMENTAL STUDY OF SPECIFIC ACTIVITY OF 1,3-DIAZINON-4 COMPOUND PYaTdl DERIVATIVE IN VIVO

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2016
Aim. Study anti-leprosy activity of a 1.3-diazinon-4 compound derivative under the laboratory code PYaTd 1 on the model of intra-plantar infection of mice and evaluate the character of its antibacterial effect. Materials and methods.
S. A. Luzhnova   +5 more
doaj   +1 more source

Performance Assessment of Six Public Health Programs in Katsina State, Nigeria [PDF]

open access: yes, 2019
This research aimed to evaluate the performance of six ongoing public health programs through core performance indicators in Katsina State, Nigeria. The healthcare delivery in Africa is mostly program-based.
Bhalla, D. (Devender)   +2 more
core   +3 more sources

Eliminating Leprosy? [PDF]

open access: yesSkin Health and Disease, 2021
I read with great interest, the study by Mowla MR et al.1 Unfortunately, the World Health Organization (WHO)'s rhetoric in the relevant programme has led to the impression, at least in some quarters, that leprosy no longer exists. Furthermore, it is likely that neither funders nor young researchers are attracted to an officially 'eliminated' disease ...
openaire   +3 more sources

Tracing leprosy trends in Pakistan: a two-decade analysis of geographic and demographic shifts (2001–2023)

open access: yesBMC Global and Public Health
Background Leprosy, or Hansen’s disease, is caused by Mycobacterium leprae and can lead to severe disabilities, social marginalisation and reduced quality of life.
Anil Fastenau   +11 more
doaj   +1 more source

BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control.

open access: yes, 2010
The bacillus Calmette-Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses did not provide a summary estimate of the efficacy due to the
Cunha, Sergio S   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy